Barclays on U.S. Specialty Pharmaceuticals: Muddling Now, but Opportunity Remains

Go back to Barclays on U.S. Specialty Pharmaceuticals: Muddling Now, but Opportunity Remains
Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 32.18 --0 (-0%)
Previous Close $32.18    52 Week High $66.55 
Open $32.18    52 Week Low $37.82 
Day High $32.18    P/E N/A 
Day Low $32.18    EPS $0.00 
Volume 3,797       

Watson Pharmaceuticals, Inc. (NYSE: WPI) Delayed: 85.73 --0 (-0%)
Previous Close $85.73    52 Week High $91.47 
Open $16.30    52 Week Low $57.16 
Day High $85.73    P/E 66.46 
Day Low $85.73    EPS $1.29 
Volume 3,625